Dysentery primary prevention

Jump to navigation Jump to search

Dysentery Microchapters

Home

Patient Information

Overview

Pathophysiology

Causes

Differentiating Dysentery from other Diseases

Epidemiology and Demographics

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Case Studies

Case #1

Dysentery primary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

slides

Images

American Roentgen Ray Society Images of Dysentery primary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Dysentery primary prevention

on Dysentery primary prevention

Dysentery primary prevention in the news

Blogs on Dysentery primary prevention

Directions to Hospitals Treating Dysentery

Risk calculators and risk factors for Dysentery primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Kalsang Dolma, M.B.B.S.[2]

Primary Prevention

To reduce the risk of contracting dysentery the following precautions are suggested:[1]

  • Washing one's hands after using the toilet, after contact with an infected person, and regularly throughout the day.
  • Washing one's hands before handling, cooking and eating food, handling babies, and feeding young or elderly people.
  • Keeping contact with someone known to have dysentery to a minimum.
  • Washing laundry on the hottest setting possible.
  • Avoiding sharing items such as towels and face cloths.

Vaccines currently in development may eventually become a critical part of the strategy to reduce the incidence and severity of diarrhea, particularly among children in low-resource settings. For example, Shigella is a longstanding World Health Organization (WHO) target for vaccine development, and sharp declines in age-specific diarrhea/dysentery attack rates for this pathogen indicate that natural immunity does develop following exposure; thus, vaccination to prevent this disease should be feasible. Currently, no licensed vaccine targeting Shigella exists. The development of vaccines against these types of infection has been hampered by technical constraints, insufficient support for coordination, and a lack of market forces for research and development. Most vaccine development efforts are taking place in the public sector or as research programs within biotechnology companies. Several vaccine candidates are currently in various phases of research and development, including a number of ongoing clinical trials.[2]

References

  1. Hicks, Rob (January 2008). "BBC - Health: Dysentery". British Broadcasting Company. Retrieved February 5, 2011.
  2. Vaccine Resource Library. "More about [[shigellosis]] and [[enterotoxigenic Escherichia coli]] (ETEC)". Retrieved 2 May 2012. URL–wikilink conflict (help)

Template:WH Template:WS